Tags : Presented

Viewpoints

ViewPoints Interview: Janssen’s Andrew Greenspan Shares Insights on the Data

In a recent interview with PharmaShots, Andrew Greenspan, MD, VP Medical Affairs of Janssen Immunology shared his views on Janssen’s commitment to advance research in rheumatic disease. Shots: Janssen presented clinical trial results in 35 abstracts featuring findings across PsA, RA, and SLE at ACR Convergence 2020 Virtual Scientific Program Sixteen abstracts focus on Tremfya […]Read More

Viewpoints

ViewPoints Interview: ViiV Healthcare’s Kimberly Smith Shares Insight on Data

In a recent interview with PharmaShots, Kimberly Smith, MD, MPH, Head of Research & Development at ViiV Healthcare shared information on the positive findings presented at the 2020 Infectious Diseases Society of America (IDWeek) and the impact of COVID-19 on the development of long-acting cabotegravir and rilpivirine. Shots: The company reported the positive findings of […]Read More

Pharma

Boehringer Ingelheim (BI) & Eli Lilly Reports RWE Results of

Shots:   The EMPRISE study involves assessing of Jardiance vs DPP-4 inhibitors in ~35,000 people with T2D initiated from 2014 to 2019, demonstrated 44% reduction in relative risk of hospitalization for HHF and was consistent in patients with or without CV diseases The above results support finding from EMPA-REG OUTCOME trial assessing jardiance (10/25 mg […]Read More